Eileen M. O'Reilly, MD

Chair of Medical Oncology
Memorial Sloan Kettering Cancer Center, United States

Presentation(s):

• 42: Salvage Hepatic Artery Infusion Chemotherapy after First Line Systemic Failure in Patients with Unresectable Cholangiocarcinoma

  Thursday, March 21, 2024
  2:02pm – 2:12pm ET

• 45: Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)

  Thursday, March 21, 2024
  2:32pm – 2:42pm ET

• P35: Extrahepatic Cholangiocarcinoma: Genomic Variables Associated with Anatomical Location and Outcome

  Friday, March 22, 2024
  1:52pm – 1:58pm ET